[HTML] springer.comFull View

[HTML][HTML] LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

G Jia, Y Wang, C Lin, S Lai, H Dai, Z Wang… - Journal of Experimental …, 2021 - Springer
Background Mounting evidence has suggested the essential role of long non-coding RNAs
(lncRNAs) in a plethora of malignant tumors, including hepatocellular carcinoma. However …
被引用次数：58 相关文章

LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.

G Jia, Y Wang, C Lin, S Lai, H Dai… - … of Experimental & …, 2021 - search.ebscohost.com
Background: Mounting evidence has suggested the essential role of long non-coding RNAs
(lncRNAs) in a plethora of malignant tumors, including hepatocellular carcinoma. However …
[HTML] biomedcentral.com

[HTML][HTML] RETRACTED ARTICLE: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform …

G Jia, Y Wang, C Lin, S Lai, H Dai… - … of Experimental & …, 2021 - jeccr.biomedcentral.com
Mounting evidence has suggested the essential role of long non-coding RNAs (lncRNAs) in
a plethora of malignant tumors, including hepatocellular carcinoma. However, the …

LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.

G Jia, Y Wang, C Lin, S Lai, H Dai, Z Wang… - … of Experimental & …, 2021 - go.gale.com
Background Mounting evidence has suggested the essential role of long non-coding RNAs
(lncRNAs) in a plethora of malignant tumors, including hepatocellular carcinoma. However …
[PDF] archive.org

[PDF][PDF] LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

G Jia, Y Wang, C Lin, S Lai, H Dai, Z Wang, L Dai, H Su… - 2021 - scholar.archive.org
Background: Mounting evidence has suggested the essential role of long non-coding RNAs
(lncRNAs) in a plethora of malignant tumors, including hepatocellular carcinoma. However …

LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.

G Jia, Y Wang, C Lin, S Lai, H Dai, Z Wang… - … of Experimental & …, 2021 - europepmc.org
Background Mounting evidence has suggested the essential role of long non-coding RNAs
(lncRNAs) in a plethora of malignant tumors, including hepatocellular carcinoma. However …

LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

G Jia, Y Wang, C Lin, S Lai, H Dai… - … of experimental & …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Mounting evidence has suggested the essential role of long non-coding RNAs
(lncRNAs) in a plethora of malignant tumors, including hepatocellular carcinoma. However …
[HTML] nih.gov

[HTML][HTML] LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

G Jia, Y Wang, C Lin, S Lai, H Dai, Z Wang… - … of Experimental & …, 2021 - ncbi.nlm.nih.gov
Background Mounting evidence has suggested the essential role of long non-coding RNAs
(lncRNAs) in a plethora of malignant tumors, including hepatocellular carcinoma. However …

LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

G Jia, Y Wang, C Lin, S Lai, H Dai… - … of Experimental and …, 2021 - search.proquest.com
Background Mounting evidence has suggested the essential role of long non-coding RNAs
(lncRNAs) in a plethora of malignant tumors, including hepatocellular carcinoma. However …
[HTML] biomedcentral.com

[HTML][HTML] RETRACTED ARTICLE: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform …

G Jia, Y Wang, C Lin, S Lai, H Dai… - … of Experimental & …, 2021 - jeccr.biomedcentral.com
Mounting evidence has suggested the essential role of long non-coding RNAs (lncRNAs) in
a plethora of malignant tumors, including hepatocellular carcinoma. However, the …